Oral-Based Diagnostics

Oral-based diagnostics have the potential to detect systemic disease and evidence of exposure to various harmful substances, as well as provide biomarkers of health and disease status. Integration of novel approaches to oral based diagnostics is expanding to include genomics, proteomics, bioinformatics and nanotechnology. Improved technologies for diagnostics are resulting in more "user-friendly" methods. Efforts to translate bench assays to commercial products in the area of oral diagnostics have increased recently as witnessed by the appearance of several new oral based diagnostic products in the market place. Collaborative academic, government and industry relationships in this arena are also forming all of which will undoubtedly serve to rapidly advance the field. One of the aims of this symposium is to bring together leaders in the areas of toxicology, pathology, oral biology, dental research, and clinical medicine to discuss advances in the field of oral diagnostics, and to permit the initiation of new collaborations.

Conference Co-Chairs:

Daniel Malamud, PhD (New York University College of Dentistry)

R. Sam Niedbala, PhD (Lehigh University)

We gratefully acknowledge the support of:

National Institute of Dental and Craniofacial Research, Draeger Safety, Draeger USA, International Diagnostic Systems, Lehigh Universtiy, NYU College of Dentistry, Orasure, Salimetrics, StatSure Diagnostic Systems (SDS), K Street Associates, LLC

Funding for this conference was made possible (in part) by R13 DE017852 from the National Institute of Dental and Craniofacial Research (NIDCR). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.